Judith A. James - Publications

Affiliations: 
University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States 
Area:
Immunology, Microbiology Biology

301 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Chakravarty EF, Utset T, Kamen DL, Contreras G, McCune WJ, Aranow C, Kalunian K, Massarotti E, Clowse MEB, Rovin BH, Lim SS, Majithia V, Dall'Era M, Looney RJ, Erkan D, ... ... James JA, et al. Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial. The Lancet. Rheumatology. PMID 38301682 DOI: 10.1016/S2665-9913(23)00320-X  0.308
2022 Laurynenka V, Ding L, Kaufman KM, James JA, Harley JB. A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies. Frontiers in Immunology. 13: 830993. PMID 35251022 DOI: 10.3389/fimmu.2022.830993  0.369
2021 Wood RA, Guthridge L, Thurmond E, Guthridge CJ, Kheir JM, Bourn RL, Wagner CA, Chen H, DeJager W, Macwana SR, Kamp S, Lu R, Arriens C, Chakravarty EF, Thanou A, ... ... James JA, et al. Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus. Journal of Translational Autoimmunity. 4: 100117. PMID 35005588 DOI: 10.1016/j.jtauto.2021.100117  0.376
2021 Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, Cheung P, Chinthrajah S, Dhingra S, Do E, Finck A, ... ... James JA, et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nature Communications. 12: 5417. PMID 34521836 DOI: 10.1038/s41467-021-25509-3  0.36
2021 Bagavant H, Araszkiewicz AM, Ingram JK, Cizio K, Merrill JT, Arriens C, Guthridge JM, James JA, Deshmukh US. Immune Response to  in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies. Frontiers in Immunology. 12: 635072. PMID 34122404 DOI: 10.3389/fimmu.2021.635072  0.408
2021 Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, Cheung P, Chinthrajah S, Dhingra S, Do E, Finck A, ... ... James J, et al. New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19. Medrxiv : the Preprint Server For Health Sciences. PMID 33532787 DOI: 10.1101/2021.01.27.21250559  0.374
2020 Jog NR, James JA. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus. Frontiers in Immunology. 11: 623944. PMID 33613559 DOI: 10.3389/fimmu.2020.623944  0.318
2020 Munroe ME, Anderson JR, Gross TF, Stunz LL, Bishop GA, James JA. Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity. Frontiers in Immunology. 11: 606936. PMID 33613527 DOI: 10.3389/fimmu.2020.606936  0.311
2020 Raj P, Song R, Zhu H, Riediger L, Jun DJ, Liang C, Arana C, Zhang B, Gao Y, Wakeland BE, Dozmorov I, Zhou J, Kelly JA, Lauwerys BR, Guthridge JM, ... ... James JA, et al. Deep sequencing reveals a DAP1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus. Genome Biology. 21: 281. PMID 33213505 DOI: 10.1186/s13059-020-02184-z  0.365
2020 Merrill JT, Erkan D, Winakur J, James JA. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nature Reviews. Rheumatology. PMID 32733003 DOI: 10.1038/S41584-020-0474-5  0.315
2020 Shah HB, Smith K, Scott Ii EJ, Larabee JL, James JA, Ballard JD, Lang ML. Human C. difficile toxin-specific memory B cell repertoires encode poorly-neutralizing antibodies. Jci Insight. PMID 32663199 DOI: 10.1172/Jci.Insight.138137  0.312
2020 Hahn J, Leatherwood C, Malspeis S, Liu X, Lu B, Roberts AL, Sparks JA, Karlson EW, Feldman CH, Munroe ME, James JA, Kubzansky LD, Costenbader KH. Associations between daily alcohol consumption and systemic lupus erythematosus-related cytokines and chemokines among US female nurses without SLE. Lupus. 961203320929427. PMID 32507075 DOI: 10.1177/0961203320929427  0.349
2020 Slight-Webb S, Smith M, Bylinska A, Macwana S, Guthridge C, Lu R, Merrill JT, Chakravarty E, Arriens C, Munroe ME, Maecker HT, Utz PJ, Guthridge JM, James JA. Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype. The Journal of Allergy and Clinical Immunology. PMID 32446964 DOI: 10.1016/J.Jaci.2020.04.047  0.415
2020 Arriens C, Alexander RV, Narain S, Saxena A, Collins CE, Wallace DJ, Massarotti E, Conklin J, Kalunian KC, Putterman C, Ramsey-Goldman R, Buyon JP, Askanase A, Furie RA, James JA, et al. Cell-bound complement activation products associate with lupus severity in SLE. Lupus Science & Medicine. 7. PMID 32371480 DOI: 10.1136/Lupus-2019-000377  0.31
2020 Dumas EK, Demiraslan H, Ingram RJ, Sparks RM, Muns E, Zamora A, Larabee J, Garman L, Ballard JD, Boons GJ, James JA, Kayabas U, Doganay M, Farris AD. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes. Plos One. 15: e0230782. PMID 32294093 DOI: 10.1371/Journal.Pone.0230782  0.402
2020 Guthridge JM, Lu R, Tran LT, Arriens C, Aberle T, Kamp S, Munroe ME, Dominguez N, Gross T, DeJager W, Macwana SR, Bourn RL, Apel S, Thanou A, Chen H, ... ... James JA, et al. Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study. Eclinicalmedicine. 20: 100291. PMID 32154507 DOI: 10.1016/J.Eclinm.2020.100291  0.354
2020 Chakravarty E, Utset T, Kamen DL, Contreras G, Mccune WJ, Kalunian KC, Aranow C, Clowse M, Goldmuntz E, Springer J, Keyes-Elstein L, Barry B, Pinckney A, James J. Op0167 Successful Withdrawal Of Mycophenolate Mofetil In Quiescent Sle: Results From A Randomized Trial Annals of the Rheumatic Diseases. 79: 105-106. DOI: 10.1136/Annrheumdis-2020-Eular.5110  0.319
2020 Wiley MM, Khatri B, Tessneer KL, Joachims ML, Stolarczyk AM, Rasmussen A, Bowman SJ, Radfar L, Omdal R, Wahren-Herlenius M, Warner BM, Witte T, Jonsson R, Rischmueller M, Gaffney PM, ... James JA, et al. Op0139 Functional Evaluation Of The Sjögren’S Syndrome And Systemic Lupus Erythematosus Ddx6-Cxcr5 Risk Interval Annals of the Rheumatic Diseases. 79: 89-90. DOI: 10.1136/Annrheumdis-2020-Eular.3935  0.333
2020 Khatri B, Reksten TR, Tessneer KL, Rasmussen A, Scofield RH, Bowman SJ, Guthridge J, James JA, Ronnblom L, Warner BM, Mariette X, Omdal R, Ibanez JM, Teruel M, Jensen JL, et al. Op0047 Genome-Wide Association Study Of Sjögren’S Syndrome Identifies Ten New Risk Loci Annals of the Rheumatic Diseases. 79: 30-31. DOI: 10.1136/Annrheumdis-2020-Eular.3857  0.346
2019 Thanou A, James JA, Arriens C, Aberle T, Chakravarty E, Rawdon J, Stavrakis S, Merrill JT, Askanase A. Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures. Lupus Science & Medicine. 6: e000365. PMID 31921432 DOI: 10.1136/Lupus-2019-000365  0.345
2019 Slight-Webb S, Bourn RL, Holers VM, James JA. Shared and unique immune alterations in pre-clinical autoimmunity. Current Opinion in Immunology. 61: 60-68. PMID 31557691 DOI: 10.1016/J.Coi.2019.08.006  0.375
2019 Jog NR, McClain MT, Heinlen LD, Gross T, Towner R, Guthridge JM, Axtell RC, Pardo G, Harley JB, James JA. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. Journal of Autoimmunity. 102332. PMID 31515129 DOI: 10.1016/J.Jaut.2019.102332  0.801
2019 Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, Kamen DL, Gilkeson GS, Weisman MH, Karp DR, Gaffney PM, Harley JB, Wallace DJ, Norris JM, James JA. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Annals of the Rheumatic Diseases. PMID 31217170 DOI: 10.1136/Annrheumdis-2019-215361  0.452
2019 Lu R, Guthridge JM, Chen H, Bourn RL, Kamp S, Munroe ME, Macwana SR, Bean K, Sridharan S, Merrill JT, James JA. Immunologic findings precede rapid lupus flare after transient steroid therapy. Scientific Reports. 9: 8590. PMID 31197240 DOI: 10.1038/S41598-019-45135-W  0.375
2019 Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabathou S, Izmirly P, Clancy R, Belmont HM, Koenigsberg M, Mokrzycki M, Rominieki H, Graham JA, Rocca JP, Bornkamp N, ... ... James J, et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nature Immunology. PMID 31110316 DOI: 10.1038/S41590-019-0386-1  0.309
2019 James JA, Chen H, Young KA, Bemis EA, Seifert J, Bourn RL, Deane KD, Demoruelle MK, Feser M, O'Dell JR, Weisman MH, Keating RM, Gaffney PM, Kelly JA, Langefeld CD, et al. Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients. Ebiomedicine. PMID 30952617 DOI: 10.1016/J.Ebiom.2019.03.063  0.38
2019 Young KA, Munroe ME, Guthridge JM, Kamen DL, Gilkensen GS, Harley JB, Weisman MH, Karp DR, Wallace DJ, James JA, Norris JM. Screening characteristics for enrichment of individuals at higher risk for transitioning to classified SLE. Lupus. 961203319834675. PMID 30845880 DOI: 10.1177/0961203319834675  0.347
2019 Stathopoulos P, Chastre A, Waters P, Irani S, Fichtner ML, Benotti ES, Guthridge JM, Seifert J, Nowak RJ, Buckner JH, Holers VM, James JA, Hafler DA, O'Connor KC. Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 30824481 DOI: 10.4049/Jimmunol.1801295  0.403
2019 Wang Z, Liu X, Muther J, James JA, Smith K, Wu S. Top-down Mass Spectrometry Analysis of Human Serum Autoantibody Antigen-Binding Fragments. Scientific Reports. 9: 2345. PMID 30787393 DOI: 10.1038/S41598-018-38380-Y  0.436
2019 Ghodke-Puranik Y, Imgruet M, Dorschner JM, Shrestha P, McCoy K, Kelly JA, Marion M, Guthridge JM, Langefeld CD, Harley JB, James JA, Sivils KL, Niewold TB. Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen. Cytokine. PMID 30685201 DOI: 10.1016/J.Cyto.2018.12.014  0.378
2019 Slight-Webb S, Guthridge JM, Chakravarty EF, Chen H, Lu R, Macwana S, Bean K, Maecker HT, Utz PJ, James JA. Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients. Jci Insight. 4. PMID 30674728 DOI: 10.1172/Jci.Insight.124575  0.432
2019 Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabothu S, Izmirly P, Clancy R, Belmont M, Koenigsberg M, Mokrzycki M, Rominiecki H, Graham J, Rocca J, Bornkamp N, ... ... James JA, et al. 300 Insights from single-cell RNA sequencing of skin and kidney in lupus nephritis Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.300  0.331
2019 Smith M, Slight-Webb S, Macwana S, Chakravarty E, Arriens C, Merrill JT, James JA, Guthridge J. 296 Activated stress response genes and perturbation of regulatory pathways in anti-nuclear antibody positive individuals and SLE patients vary by cell type and race in single-cell transcriptomic analyses Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.296  0.394
2019 Slight-Webb S, Smith M, Chakravarty E, Arriens C, Aberle T, Maecker H, Utz PJ, Guthridge J, James JA. 287 African american SLE patients with variable disease activity reveal alterations in signaling pathways and soluble mediators that are more pronounced than european american patients Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.287  0.388
2019 Slight-Webb S, Bylinska A, Smith M, Lu R, Chen H, Bean K, Munroe M, Maecker H, Utz PJ, Merrill JT, Chakravarty E, Arriens C, Guthridge J, James JA. 233 Autoantibody-positive healthy individuals constrain T cell pathways to regulate autoimmune disease Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.233  0.385
2019 Arriens C, Chen S, Karp DR, Saxena R, Merrill JT, James JA. 21 Is lupus nephritis onset delayed in older caucasian females with less aggressive pathology Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.21  0.386
2019 Arriens C, Forciea D, Carthen F, McCance D, James JA, Merrill JT. 100 Differing opinions on clinical research between healthcare providers and lupus patients Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.100  0.319
2019 Guthridge C, Gross T, Quintero M, Kheir J, Guthridge J, James JA. Thu0263 Novel Subsets Of Sle Patients Enriched For Renal Manifestations Identified By Clustering With Expanded Autoantibody Profiles Of Native American (Na), African American (Aa), And European American (Ea) Sle Patients Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.7526  0.32
2019 Merrill J, June J, Koumpouras F, Machua W, Khan MF, Askanase A, Khosroshahi A, Sheikh S, James JA, Guthridge J, Rathi G, Burington B, Foster P, Zack D. Fri0176 Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Of A Reversible B Cell Inhibitor, Xmab®5871, In Systemic Lupus Erythematosus (Sle) Annals of the Rheumatic Diseases. 78: 761-762. DOI: 10.1136/Annrheumdis-2019-Eular.4234  0.364
2019 Thanou A, Arriens C, Aberle T, Chakravary E, Vaseer S, Rawdon J, James JA, Merrill J. Fri0213 Randomized Placebo Controlled Trial Of Abatacept For Non-Organ Threatening Systemic Lupus With Background Medications Withdrawn Annals of the Rheumatic Diseases. 78: 786-786. DOI: 10.1136/Annrheumdis-2019-Eular.2526  0.374
2018 Shah HB, Smith K, Wren JD, Webb CF, Ballard JD, Bourn RL, James JA, Lang ML. Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires. Frontiers in Immunology. 9: 3064. PMID 30697210 DOI: 10.3389/Fimmu.2018.03064  0.318
2018 Olsen NJ, James JA, Arriens C, Ishimori ML, Wallace DJ, Kamen DL, Chong BF, Liao D, Chinchilli VM, Karp DR. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial. Trials. 19: 694. PMID 30572906 DOI: 10.1186/S13063-018-3076-7  0.417
2018 Jog NR, Chakravarty EF, Guthridge JM, James JA. Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes. Frontiers in Immunology. 9: 2198. PMID 30356670 DOI: 10.3389/Fimmu.2018.02198  0.371
2018 Ratliff ML, Garton J, Garman L, Barron MD, Georgescu C, White KA, Chakravarty E, Wren JD, Montgomery CG, James JA, Webb CF. ARID3a gene profiles are strongly associated with human interferon alpha production. Journal of Autoimmunity. PMID 30297159 DOI: 10.1016/J.Jaut.2018.09.013  0.382
2018 Martínez-Bueno M, Oparina N, Dozmorov MG, Marion MC, Comeau ME, Gilkeson G, Kamen D, Weisman M, Salmon J, McCune JW, Harley JB, Kimberly R, James JA, Merrill J, Montgomery C, et al. Trans-Ethnic Mapping of Identifies Two Independent SLE-Risk Linkage Groups Enriched for Co-Transcriptional Splicing Marks. International Journal of Molecular Sciences. 19. PMID 30096841 DOI: 10.3390/Ijms19082331  0.315
2018 Hanscombe KB, Morris DL, Noble JA, Dilthey AT, Tombleson P, Kaufman KM, Comeau M, Langefeld CD, Alarcon-Riquelme ME, Gaffney PM, Jacob CO, Sivils KL, Tsao BP, Alarcon GS, Brown EE, ... ... James JA, et al. Genetic fine mapping of Systemic Lupus Erythematosus MHC associations in Europeans and African Americans. Human Molecular Genetics. PMID 30085094 DOI: 10.1093/Hmg/Ddy280  0.315
2018 Bagavant H, Dunkleberger ML, Wolska N, Sroka M, Rasmussen A, Adrianto I, Montgomery C, Sivils K, Guthridge JM, James JA, Merrill JT, Deshmukh US. Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients. Clinical and Experimental Rheumatology. PMID 29998833  0.308
2018 Patel Z, Lu X, Miller D, Forney CR, Lee J, Lynch A, Schroeder C, Parks L, Magnusen AF, Chen X, Pujato M, Maddox A, Zoller EE, Namjou B, Brunner HI, ... ... James JA, et al. A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Human Molecular Genetics. PMID 29912393 DOI: 10.1093/Hmg/Ddy140  0.349
2018 Kheir JM, Guthridge CJ, Johnston JR, Adams LJ, Rasmussen A, Gross TF, Munroe ME, Bourn RL, Sivils KL, Guthridge JM, Weisman MH, Wallace DJ, Anaya JM, Rojas Villarraga A, Jarvis JN, ... ... James JA, et al. Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus. Lupus Science & Medicine. 5: e000247. PMID 29531773 DOI: 10.1136/Lupus-2017-000247  0.439
2018 Koelsch KA, Cavett J, Smith K, Moore JS, Lehoux SD, Jia N, Mather T, Quadri SMS, Rasmussen A, Kaufman CE, Lewis DM, Radfar L, Scordino TA, Lessard CJ, Kurien BT, ... ... James JA, et al. Evidence for Alternate Modes of B cell Activation Involving Fab Acquired-N-Glycosylations in Antibody Secreting Cells Infiltrating the Labial Salivary Glands of Sjögren's Syndrome Patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29457375 DOI: 10.1002/Art.40458  0.354
2018 Raj P, Pichilingue-Reto P, Dozmorov I, Song R, Liang C, Arana C, Cantarel B, Kim D, Zhang B, Zhou J, Molina E, Gregersen PK, James JA, Karp DR, Morena MTdl, et al. GG-08 Immune repertoire and genetic risk alleles in healthy pediatric populations with autoimmune indicators Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.95  0.383
2018 Raj P, Song R, Wakeland BE, Dozmorov I, Viswanathan K, Liang C, Arana C, Zhang B, Zhou J, Lauwerys BR, Olsen NJ, Nath S, Gregersen PK, James JA, Tsao BP, et al. GG-07 Regulatory polymorphisms in EMSY gene are associated with autoantibodies in healthy individuals Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.94  0.487
2018 Askanase AD, Thanou A, James JA, Arriens C, Aberle T, Chakravarty E, Rawdon J, Kamp S, Stavrakis S, Merrill JT. CS-05 Can systemic lupus erythematosus (SLE) disease activity be consistently scored and interpreted with simple, rapid outcome measures? Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.40  0.35
2018 Guthridge JM, Lu R, Arriens C, Aberle T, Kamp S, Munroe ME, Gross T, DeJager W, Macwana SR, Bourn RL, Apel S, Chen H, Chakravarty EF, Thanou A, Merrill JT, ... James JA, et al. SAT0423 Molecular profiles associate with clinical disease activity and inform patient subsetting in adult systemic lupus erythematosus Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2018-Eular.6054  0.392
2018 Thanou A, Arriens C, Aberle T, James JA, Merrill JT, Askanase AD. THU0342 The lupus foundation of america rapid evaluation of activity in lupus (LFA-REAL) provides a simple but reliable measurement of sle disease activity Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2018-Eular.5613  0.328
2018 Wood R, Guthridge L, Thurmond E, Guthridge C, Chen H, deJager W, Macwana S, Bourn RL, Kamp S, Lu R, Arriens C, Chakravarty EF, Thanou A, Merrill J, Guthridge J, ... James JA, et al. FRI0287 Serologic evidence of viral reactivation and increased disease activity in patients with systemic lupus erythematosus Annals of the Rheumatic Diseases. 77: 681-681. DOI: 10.1136/Annrheumdis-2018-Eular.5592  0.495
2018 Means N, Ice JA, Adrianto I, Stolarczyk AM, Joachims ML, Rasmussen A, Guthridge JM, James JA, Scofield RH, Sivils KL, Lessard CJ. FRI0270 Identification of novel dysregulated interferon-inducible non-coding rnas in sjÖgren’s syndrome Annals of the Rheumatic Diseases. 77: 674-674. DOI: 10.1136/Annrheumdis-2018-Eular.4837  0.339
2017 Jog NR, James JA. Biomarkers in connective tissue diseases. The Journal of Allergy and Clinical Immunology. 140: 1473-1483. PMID 29221579 DOI: 10.1016/J.Jaci.2017.10.003  0.38
2017 Vista ES, Weisman MH, Ishimori ML, Chen H, Bourn RL, Bruner BF, Hamijoyo L, Tanangunan RD, Gal NJ, Robertson JM, Harley JB, Guthridge JM, Navarra SV, James JA. Strong viral associations with SLE among Filipinos. Lupus Science & Medicine. 4: e000214. PMID 29214036 DOI: 10.1136/Lupus-2017-000214  0.346
2017 Glauzy S, Boccitto M, Bannock JM, Delmotte FR, Saadoun D, Cacoub P, Ice JA, Sivils KL, James JA, Wolin SL, Meffre E. Antigen-driven lymphoproliferations in Sjögren's Syndrome patients accumulate in complement receptor 2/CD21(-/low) B cells. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29073352 DOI: 10.1002/Art.40352  0.311
2017 Dumas EK, Gross T, Larabee J, Pate L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Collins LC, Spooner CE, Chen H, Ballard J, James JA, Farris AD. Anthrax Vaccine Precipitated induces Edema Toxin-neutralizing, Edema Factor-specific antibodies in human recipients. Clinical and Vaccine Immunology : Cvi. PMID 28877928 DOI: 10.1128/Cvi.00165-17  0.328
2017 Langefeld CD, Ainsworth HC, Graham DSC, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, ... ... James JA, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nature Communications. 8: 16021. PMID 28714469 DOI: 10.1038/Ncomms16021  0.409
2017 Li H, Reksten TR, Ice JA, Kelly JA, Adrianto I, Rasmussen A, Wang S, He B, Grundahl KM, Glenn SB, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, ... ... James JA, et al. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. Plos Genetics. 13: e1006820. PMID 28640813 DOI: 10.1371/Journal.Pgen.1006820  0.36
2017 Dumas EK, Garman L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Choudhari S, Picking WD, James JA, Farris AD. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated. Vaccine. PMID 28504191 DOI: 10.1016/J.Vaccine.2017.05.006  0.3
2017 Aberle T, Bourn RL, Chen H, Roberts VC, Guthridge JM, Bean K, Robertson JM, Sivils KL, Rasmussen A, Liles M, Merrill JT, Harley JB, Olsen NJ, Karp DR, James JA. Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupus. Lupus Science & Medicine. 4: e000176. PMID 28409015 DOI: 10.1136/Lupus-2016-000176  0.381
2017 Merrill JT, Immermann F, Whitley M, Zhou T, Hill A, O'Toole M, Reddy P, Honczarenko M, Thanou A, Rawdon J, Guthridge JM, James JA, Sridharan S. The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28257602 DOI: 10.1002/Art.40086  0.348
2017 Munroe ME, Pezant N, Brown MA, Fife DA, Guthridge JM, Kelly JA, Wiley G, Gaffney PM, James JA, Montgomery CG. Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis. Plos One. 12: e0171193. PMID 28234905 DOI: 10.1371/Journal.Pone.0171193  0.354
2017 Munroe ME, Vista ES, Merrill JT, Guthridge JM, Roberts VC, James JA. Pathways of impending disease flare in African-American systemic lupus erythematosus patients. Journal of Autoimmunity. PMID 28162788 DOI: 10.1016/J.Jaut.2016.12.005  0.427
2017 Aberle T, Bourn RL, Munroe ME, Chen H, Roberts VC, Guthridge JM, Bean K, Robertson JM, Sivils KL, Rasmussen A, Liles M, Merrill JT, Harley JB, Olsen NJ, Karp DR, ... James JA, et al. Clinical and serological features distinguish patients with incomplete lupus classification from systemic lupus erythematosus patients and controls. Arthritis Care & Research. PMID 28118528 DOI: 10.1002/Acr.23201  0.358
2017 Karp D, Chong B, Arriens C, James J, Ishimori M, Weisman M, Wallace D, Olsen N. 249 Likelihood of patients with incomplete lupus to enter a randomised, placebo-controlled trial of hydroxychloroquine Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.249  0.314
2017 Thanou A, Stavrakis S, Reynolds J, Kamp S, Kamp P, James J, Merrill J. AB0475 Changes in heart rate variability reflect changes in clinical status and patient reported outcomes in systemic lupus erythematosus: a longitudinal analysis Annals of the Rheumatic Diseases. 76: 1217-1217. DOI: 10.1136/Annrheumdis-2017-Eular.5425  0.346
2016 Arriens C, Chen S, Karp DR, Saxena R, Sambandam K, Chakravarty E, James JA, Merrill JT. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death. Clinical Immunology (Orlando, Fla.). PMID 27923701 DOI: 10.1016/J.Clim.2016.11.019  0.326
2016 Munroe ME, Young KA, Kamen DL, Guthridge JM, Niewold TB, Costenbader KH, Weisman MH, Ishimori ML, Wallace DJ, Gilkeson GS, Karp DR, Harley JB, Norris JM, James JA. Soluble Mediators and Clinical Features Discern Risk of Transitioning to Classified Disease in Relatives of Systemic Lupus Erythematosus Patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27863174 DOI: 10.1002/Art.40004  0.411
2016 Ward JM, Ratliff ML, Dozmorov MG, Wiley G, Guthridge JM, Gaffney PM, James JA, Webb CF. Expression and methylation data from SLE patient and healthy control blood samples subdivided with respect to ARID3a levels. Data in Brief. 9: 213-9. PMID 27656675 DOI: 10.1016/J.Dib.2016.08.049  0.307
2016 Thanou A, Stavrakis S, Dyer JW, Munroe ME, James JA, Merrill JT. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity. Arthritis Research & Therapy. 18: 197. PMID 27590046 DOI: 10.1186/S13075-016-1087-X  0.337
2016 Ward JM, Ratliff ML, Dozmorov MG, Wiley G, Guthridge JM, Gaffney PM, James JA, Webb CF. Human effector B lymphocytes express ARID3a and secrete interferon alpha. Journal of Autoimmunity. PMID 27522115 DOI: 10.1016/J.Jaut.2016.08.003  0.332
2016 Lu R, Munroe ME, Guthridge JM, Bean KM, Fife DA, Chen H, Slight-Webb SR, Keith MP, Harley JB, James JA. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. Journal of Autoimmunity. PMID 27338520 DOI: 10.1016/J.Jaut.2016.06.001  0.417
2016 Young KA, Munroe ME, Guthridge JM, Kamen DL, Niewold TB, Gilkeson GS, Weisman MH, Ishimori ML, Kelly J, Gaffney PM, Sivils KH, Lu R, Wallace DJ, Karp DR, Harley JB, ... James JA, et al. Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 27283331 DOI: 10.1136/Annrheumdis-2016-209157  0.349
2016 Garman L, Smith K, Muns EE, Velte CA, Spooner CE, Munroe ME, Farris AD, Nelson MR, Engler RJ, James JA. Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions After AVA Vaccination. Clinical and Vaccine Immunology : Cvi. PMID 27280620 DOI: 10.1128/Cvi.00092-16  0.329
2016 Smith K, Shah H, Muther JJ, Duke AL, Haley K, James JA. Antigen nature and complexity influence human antibody light chain usage and specificity. Vaccine. PMID 27113164 DOI: 10.1016/J.Vaccine.2016.04.040  0.357
2016 Munroe ME, Lu R, Zhao YD, Fife DA, Robertson JM, Guthridge JM, Niewold TB, Tsokos GC, Keith MP, Harley JB, James JA. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. Annals of the Rheumatic Diseases. PMID 27088255 DOI: 10.1136/Annrheumdis-2015-208140  0.393
2016 Slight-Webb S, Lu R, Ritterhouse LL, Munroe ME, Maecker HT, Fathman CG, Utz PJ, Merrill JT, Guthridge JM, James JA. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27059145 DOI: 10.1002/Art.39706  0.692
2016 Bello GA, Brown MA, Kelly JA, Thanou A, James JA, Montgomery CG. Development and validation of a simple lupus severity index using ACR criteria for classification of SLE. Lupus Science & Medicine. 3: e000136. PMID 27026812 DOI: 10.1136/Lupus-2015-000136  0.361
2016 Raj P, Rai E, Song R, Khan S, Wakeland BE, Viswanathan K, Arana C, Liang C, Zhang B, Dozmorov I, Carr-Johnson F, Mitrovic M, Wiley GB, Kelly JA, Lauwerys BR, ... ... James JA, et al. Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. Elife. 5. PMID 26880555 DOI: 10.7554/Elife.12089  0.363
2016 Deng Y, Zhao J, Sakurai D, Sestak AL, Osadchiy V, Langefeld CD, Kaufman KM, Kelly JA, James JA, Petri MA, Bae SC, Alarcón-Riquelme ME, Alarcón GS, Anaya JM, Criswell LA, et al. Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production. Annals of the Rheumatic Diseases. PMID 26783109 DOI: 10.1136/Annrheumdis-2015-208441  0.393
2016 Munroe ME, Lu R, Slight-Webb SR, Guthridge JM, Niewold TB, Tsokos GC, Keith MP, Harley JB, James JA. I-03 Dysregulation of T helper-type cytokines and interferons appear during early systemic lupus erythematosus pathogenesis and contribute to clinical disease development Lupus Science & Medicine. 3. DOI: 10.1136/Lupus-2016-000179.68  0.431
2016 Pelikan RC, Jog N, Bebak M, Guthridge J, James J, Gaffney P. GG-05 ATAC-SEQ profiling reveals cell-type specific epigenetic features of systemic lupus erythematosus (SLE) Lupus Science & Medicine. 3. DOI: 10.1136/Lupus-2016-000179.57  0.382
2015 Ward JM, James JA, Zhao YD, Webb CF. Antibody Reactivity of B Cells in Lupus Patients with Increased Disease Activity and ARID3a Expression. Antibodies (Basel, Switzerland). 4: 354-368. PMID 28580178 DOI: 10.3390/Antib4040354  0.424
2015 Liu K, Kurien BT, Zimmerman SL, Kaufman KM, Taft DH, Kottyan LC, Lazaro S, Weaver CA, Ice JA, Adler AJ, Chodosh J, Radfar L, Rasmussen A, Stone DU, Lewis DM, ... ... James JA, et al. X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26713507 DOI: 10.1002/Art.39560  0.32
2015 Wolska N, Rybakowska P, Rasmussen A, Brown M, Montgomery C, Klopocki A, Grundahl K, Scofield RH, Radfar L, Stone DU, Anaya JM, Ice JA, Lessard CJ, Lewis DM, Rhodus NL, ... ... James JA, et al. Primary Sjögren's syndrome patients with autoantibodies against TRIM38 show greater severity of disease. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26636433 DOI: 10.1002/Art.39497  0.382
2015 Alarcón-Riquelme ME, Ziegler JT, Molineros J, Howard TD, Moreno-Estrada A, Sánchez-Rodríguez E, Ainsworth HC, Ortiz-Tello P, Comeau ME, Rasmussen A, Kelly JA, Adler A, Acevedo-Vázquez E, Cucho JM, la Torre IG, ... ... James JA, et al. GWAS in an Amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of European admixture. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26606652 DOI: 10.1002/Art.39504  0.392
2015 Munroe ME, James JA. Genetics of Lupus Nephritis: Clinical Implications. Seminars in Nephrology. 35: 396-409. PMID 26573543 DOI: 10.1016/J.Semnephrol.2015.08.002  0.396
2015 Dozmorov MG, Dominguez N, Bean K, Macwana SR, Roberts V, Glass E, James JA, Guthridge JM. B-Cell and Monocyte Contribution to Systemic Lupus Erythematosus Identified by Cell-Type-Specific Differential Expression Analysis in RNA-Seq Data. Bioinformatics and Biology Insights. 9: 11-9. PMID 26512198 DOI: 10.4137/Bbi.S29470  0.317
2015 Devera TS, Lang GA, Lanis JM, Rampuria P, Gilmore CL, James JA, Ballard JD, Lang ML. Memory B cells encode neutralizing antibody specific for Toxin B from the Clostridium difficile strains VPI 10463 and NAP1/BI/027, but with superior neutralization of VPI 10463 Toxin B. Infection and Immunity. PMID 26502913 DOI: 10.1128/Iai.00011-15  0.346
2015 Zhao J, Wu H, Langefeld CD, Kaufman KM, Kelly JA, Bae SC, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, James JA, et al. Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus. Clinical Immunology (Orlando, Fla.). PMID 26385092 DOI: 10.1016/J.Clim.2015.09.007  0.398
2015 Roskin KM, Simchoni N, Liu Y, Lee JY, Seo K, Hoh RA, Pham T, Park JH, Furman D, Dekker CL, Davis MM, James JA, Nadeau KC, Cunningham-Rundles C, Boyd SD. IgH sequences in common variable immune deficiency reveal altered B cell development and selection. Science Translational Medicine. 7: 302ra135. PMID 26311730 DOI: 10.1126/Scitranslmed.Aab1216  0.368
2015 Buyon JP, Cohen P, Merrill JT, Gilkeson G, Kaplan M, James J, McCune WJ, Bernatsky S, Elkon K. A highlight from the LUPUS 2014 meeting: eight great ideas. Lupus Science & Medicine. 2: e000087. PMID 26167290 DOI: 10.1136/Lupus-2015-000087  0.385
2015 Bourn R, James JA. Preclinical lupus. Current Opinion in Rheumatology. 27: 433-9. PMID 26125103 DOI: 10.1097/Bor.0000000000000199  0.41
2015 Kaur K, Zheng NY, Smith K, Huang M, Li L, Pauli NT, Dunand CJ, Lee JH, Morrissey M, Wu Y, Joachims ML, Munroe ME, Lau D, Qu X, Krammer F, ... ... James JA, et al. High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination. Plos One. 10: e0125618. PMID 25951191 DOI: 10.1371/Journal.Pone.0125618  0.457
2015 Lu X, Zoller EE, Weirauch MT, Wu Z, Namjou B, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, ... ... James JA, et al. Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. American Journal of Human Genetics. 96: 731-9. PMID 25865496 DOI: 10.1016/J.Ajhg.2015.03.002  0.333
2015 Fayyaz A, Igoe A, Kurien BT, Danda D, James JA, Stafford HA, Scofield RH. Haematological manifestations of lupus. Lupus Science & Medicine. 2: e000078. PMID 25861458 DOI: 10.1136/Lupus-2014-000078  0.382
2015 Edgar CE, Terrell DR, Vesely SK, Wren JD, Dozmorov IM, Niewold TB, Brown M, Zhou F, Frank MB, Merrill JT, Kremer Hovinga JA, Lämmle B, James JA, George JN, Farris AD. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. Plos One. 10: e0117614. PMID 25671313 DOI: 10.1371/Journal.Pone.0117614  0.38
2015 Martins M, Williams AH, Comeau M, Marion M, Ziegler JT, Freedman BI, Merrill JT, Glenn SB, Kelly JA, Sivils KM, James JA, Guthridge JM, Alarcón-Riquelme ME, Bae SC, Kim JH, et al. Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study. Genes and Immunity. 16: 142-50. PMID 25569266 DOI: 10.1038/Gene.2014.73  0.309
2015 Slight-Webb SR, Bagavant H, Crowe SR, James JA. Influenza A (H1N1) virus infection triggers severe pulmonary inflammation in lupus-prone mice following viral clearance. Journal of Autoimmunity. 57: 66-76. PMID 25563403 DOI: 10.1016/J.Jaut.2014.12.003  0.306
2015 Ratliff ML, Ward JM, Merrill JT, James JA, Webb CF. Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells. Journal of Immunology (Baltimore, Md. : 1950). 194: 940-9. PMID 25535283 DOI: 10.4049/Jimmunol.1401941  0.334
2015 Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, Namjou B, Adler A, Rasmussen A, Glenn S, Montgomery CG, ... ... James JA, et al. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human Molecular Genetics. 24: 582-96. PMID 25205108 DOI: 10.1093/Hmg/Ddu455  0.405
2014 Vaughn SE, Foley C, Lu X, Patel ZH, Zoller EE, Magnusen AF, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath S, Stevens AM, ... ... James JA, et al. Lupus risk variants in the PXK locus alter B-cell receptor internalization. Frontiers in Genetics. 5: 450. PMID 25620976 DOI: 10.3389/Fgene.2014.00450  0.389
2014 Robertson JM, James JA. Preclinical systemic lupus erythematosus. Rheumatic Diseases Clinics of North America. 40: 621-35. PMID 25437281 DOI: 10.1016/J.Rdc.2014.07.004  0.408
2014 Thanou A, Chakravarty E, James JA, Merrill JT. Which outcome measures in SLE clinical trials best reflect medical judgment? Lupus Science & Medicine. 1: e000005. PMID 25396057 DOI: 10.1136/Lupus-2013-000005  0.363
2014 Maier-Moore JS, Koelsch KA, Smith K, Lessard CJ, Radfar L, Lewis D, Kurien BT, Wolska N, Deshmukh U, Rasmussen A, Sivils KL, James JA, Farris AD, Scofield RH. Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). 66: 3445-56. PMID 25199908 DOI: 10.1002/Art.38872  0.418
2014 Ward JM, Rose K, Montgomery C, Adrianto I, James JA, Merrill JT, Webb CF. Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A. Arthritis & Rheumatology (Hoboken, N.J.). 66: 3404-12. PMID 25185498 DOI: 10.1002/Art.38857  0.439
2014 Zhao J, Giles BM, Taylor RL, Yette GA, Lough KM, Ng HL, Abraham LJ, Wu H, Kelly JA, Glenn SB, Adler AJ, Williams AH, Comeau ME, Ziegler JT, Marion M, ... ... James JA, et al. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Annals of the Rheumatic Diseases. PMID 25180293 DOI: 10.1136/Annrheumdis-2014-205584  0.414
2014 Lu-Fritts PY, Kottyan LC, James JA, Xie C, Buckholz JM, Pinney SM, Harley JB. Association of systemic lupus erythematosus with uranium exposure in a community living near a uranium-processing plant: a nested case-control study. Arthritis & Rheumatology (Hoboken, N.J.). 66: 3105-12. PMID 25103365 DOI: 10.1002/Art.38786  0.304
2014 James JA. Clinical perspectives on lupus genetics: advances and opportunities. Rheumatic Diseases Clinics of North America. 40: 413-32, vii. PMID 25034154 DOI: 10.1016/J.Rdc.2014.04.002  0.401
2014 Thanou A, Chakravarty E, James JA, Merrill JT. How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index. Rheumatology (Oxford, England). 53: 2175-81. PMID 24729400 DOI: 10.1093/Rheumatology/Keu153  0.346
2014 Ritterhouse LL, Lu R, Shah HB, Robertson JM, Fife DA, Maecker HT, Du H, Fathman CG, Chakravarty EF, Scofield RH, Kamen DL, Guthridge JM, James JA. Vitamin d deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European-American healthy controls. Plos One. 9: e94500. PMID 24727903 DOI: 10.1371/Journal.Pone.0094500  0.599
2014 Guthridge JM, Lu R, Sun H, Sun C, Wiley GB, Dominguez N, Macwana SR, Lessard CJ, Kim-Howard X, Cobb BL, Kaufman KM, Kelly JA, Langefeld CD, Adler AJ, Harley IT, ... ... James JA, et al. Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. American Journal of Human Genetics. 94: 586-98. PMID 24702955 DOI: 10.1016/J.Ajhg.2014.03.008  0.348
2014 Munroe ME, Vista ES, Guthridge JM, Thompson LF, Merrill JT, James JA. Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare. Arthritis & Rheumatology (Hoboken, N.J.). 66: 1888-99. PMID 24578190 DOI: 10.1002/Art.38573  0.39
2014 Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE, Birmingham DJ, Hebert LA, Hicks PJ, Segal MS, Edberg JC, Brown EE, Alarcón GS, Costenbader KH, Comeau ME, ... ... James JA, et al. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis & Rheumatology (Hoboken, N.J.). 66: 390-6. PMID 24504811 DOI: 10.1002/Art.38220  0.339
2014 Young KA, Terrell DR, Guthridge JM, Kamen DL, Gilkeson GS, Karp DR, Ishimori ML, Weisman MH, Holers VM, Harley JB, Norris JM, James JA. Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls. Lupus. 23: 360-9. PMID 24449338 DOI: 10.1177/0961203314520838  0.385
2014 Kim-Howard X, Sun C, Molineros JE, Maiti AK, Chandru H, Adler A, Wiley GB, Kaufman KM, Kottyan L, Guthridge JM, Rasmussen A, Kelly J, Sánchez E, Raj P, Li QZ, ... ... James JA, et al. Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations. Human Molecular Genetics. 23: 1656-68. PMID 24163247 DOI: 10.1093/Hmg/Ddt532  0.335
2014 Guthridge JM, Lou R, Kamp S, Munroe ME, Bean K, Macwana SR, Sridharan S, Merrill JT, James JA. THU0046 Predictive Modeling of Immunologic and Inflammatory Markers of Impending Disease Flare in Patients with Systemic Lupus Erythematosus not Taking Immunosuppressive Medications Annals of the Rheumatic Diseases. 73: 192-192. DOI: 10.1136/Annrheumdis-2014-Eular.5642  0.429
2014 Munroe M, Fife D, Robertson J, Zhao Y, Bruner B, Niewold T, Tsokos G, Keith M, Harley J, James J. OP0097 Autoantibodies Precede Interferon Elevation in Pre-Clinical Lupus Annals of the Rheumatic Diseases. 73: 98.1-98. DOI: 10.1136/Annrheumdis-2014-Eular.3402  0.379
2014 Merrill JT, Immermann FW, Zhou T, O'Toole M, Whitley M, Hill AA, Zhang Y, Schack Dv, Reddy PS, Masferrer JL, Kamp S, Guthridge JM, Thanou A, Wu P, Paradis T, ... ... James JA, et al. FRI0382 Impact of Treatments on Major Immunologic Pathways in SLE Depends on Type I Interferon Signature: Analysis from Biomarkers of Lupus Disease (BOLD) Study Annals of the Rheumatic Diseases. 73: 525-526. DOI: 10.1136/Annrheumdis-2014-Eular.2788  0.322
2013 James JA, Danda D. New perspectives and insights to Asian systemic lupus erythematosus: renal disease, genetic predisposition and disease activity. International Journal of Rheumatic Diseases. 16: 611-4. PMID 24382273 DOI: 10.1111/1756-185X.12281  0.338
2013 Kurien BT, D'Sousa A, Bruner BF, Gross T, James JA, Targoff IN, Maier-Moore JS, Harley IT, Wang H, Scofield RH. Prolidase deficiency breaks tolerance to lupus-associated antigens. International Journal of Rheumatic Diseases. 16: 674-80. PMID 24330273 DOI: 10.1111/1756-185X.12254  0.814
2013 Sakurai D, Zhao J, Deng Y, Kelly JA, Brown EE, Harley JB, Bae SC, AlarcÏŒn-Riquelme ME, Edberg JC, Kimberly RP, Ramsey-Goldman R, Petri MA, Reveille JD, Vilá LM, ... ... James JA, et al. Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. Plos Genetics. 9: e1003870. PMID 24130510 DOI: 10.1371/Journal.Pgen.1003870  0.3
2013 Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, Kelly JA, Dozmorov MG, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Gøransson LG, ... ... James JA, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nature Genetics. 45: 1284-92. PMID 24097067 DOI: 10.1038/Ng.2792  0.33
2013 Li H, Zuccolo J, Kem DC, Zillner C, Lee J, Smith K, James JA, Cunningham MW, Yu X. Implications of a vasodilatory human monoclonal autoantibody in postural hypotension. The Journal of Biological Chemistry. 288: 30734-41. PMID 24043632 DOI: 10.1074/Jbc.M113.477869  0.349
2013 Dozmorov I, Dominguez N, Sestak AL, Robertson JM, Harley JB, James JA, Guthridge JM. Evidence of dynamically dysregulated gene expression pathways in hyperresponsive B cells from African American lupus patients. Plos One. 8: e71397. PMID 23977035 DOI: 10.1371/Journal.Pone.0071397  0.316
2013 Caster DJ, Korte EA, Nanda SK, McLeish KR, Oliver RK, G'sell RT, Sheehan RM, Freeman DW, Coventry SC, Kelly JA, Guthridge JM, James JA, Sivils KL, Alarcon-Riquelme ME, Scofield RH, et al. ABIN1 dysfunction as a genetic basis for lupus nephritis. Journal of the American Society of Nephrology : Jasn. 24: 1743-54. PMID 23970121 DOI: 10.1681/Asn.2013020148  0.413
2013 Namjou B, Kim-Howard X, Sun C, Adler A, Chung SA, Kaufman KM, Kelly JA, Glenn SB, Guthridge JM, Scofield RH, Kimberly RP, Brown EE, Alarcón GS, Edberg JC, Kim JH, ... ... James JA, et al. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. Plos One. 8: e69404. PMID 23950893 DOI: 10.1371/Journal.Pone.0069404  0.361
2013 Lanis JM, Heinlen LD, James JA, Ballard JD. Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB. Plos Pathogens. 9: e1003523. PMID 23935501 DOI: 10.1371/Journal.Ppat.1003523  0.766
2013 Manku H, Langefeld CD, Guerra SG, Malik TH, Alarcon-Riquelme M, Anaya JM, Bae SC, Boackle SA, Brown EE, Criswell LA, Freedman BI, Gaffney PM, Gregersen PA, Guthridge JM, Han SH, ... ... James JA, et al. Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4. Plos Genetics. 9: e1003554. PMID 23874208 DOI: 10.1371/Journal.Pgen.1003554  0.318
2013 Saruhan-Direskeneli G, Hughes T, Aksu K, Keser G, Coit P, Aydin SZ, Alibaz-Oner F, Kamalı S, Inanc M, Carette S, Hoffman GS, Akar S, Onen F, Akkoc N, Khalidi NA, ... ... James JA, et al. Identification of multiple genetic susceptibility loci in Takayasu arteritis. American Journal of Human Genetics. 93: 298-305. PMID 23830517 DOI: 10.1016/J.Ajhg.2013.05.026  0.305
2013 Coggeshall KM, Lupu F, Ballard J, Metcalf JP, James JA, Farris D, Kurosawa S. The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax. Journal of Cellular and Molecular Medicine. 17: 914-20. PMID 23742651 DOI: 10.1111/Jcmm.12075  0.302
2013 Ramos PS, Oates JC, Kamen DL, Williams AH, Gaffney PM, Kelly JA, Kaufman KM, Kimberly RP, Niewold TB, Jacob CO, Tsao BP, Alarcón GS, Brown EE, Edberg JC, Petri MA, ... ... James JA, et al. Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry. The Journal of Rheumatology. 40: 842-9. PMID 23637325 DOI: 10.3899/Jrheum.120989  0.341
2013 Hinks A, Cobb J, Marion MC, Prahalad S, Sudman M, Bowes J, Martin P, Comeau ME, Sajuthi S, Andrews R, Brown M, Chen WM, Concannon P, Deloukas P, Edkins S, ... ... James JA, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nature Genetics. 45: 664-9. PMID 23603761 DOI: 10.1038/Ng.2614  0.354
2013 Deng Y, Zhao J, Sakurai D, Kaufman KM, Edberg JC, Kimberly RP, Kamen DL, Gilkeson GS, Jacob CO, Scofield RH, Langefeld CD, Kelly JA, Ramsey-Goldman R, Petri MA, Reveille JD, ... ... James JA, et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. Plos Genetics. 9: e1003336. PMID 23468661 DOI: 10.1371/Journal.Pgen.1003336  0.307
2013 Molineros JE, Maiti AK, Sun C, Looger LL, Han S, Kim-Howard X, Glenn S, Adler A, Kelly JA, Niewold TB, Gilkeson GS, Brown EE, Alarcón GS, Edberg JC, Petri M, ... ... James JA, et al. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. Plos Genetics. 9: e1003222. PMID 23441136 DOI: 10.1371/Journal.Pgen.1003222  0.394
2013 Dumas EK, Nguyen ML, Cox PM, Rodgers H, Peterson JL, James JA, Farris AD. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization. Vaccine. 31: 1856-63. PMID 23415781 DOI: 10.1016/J.Vaccine.2013.01.040  0.346
2013 Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, James JA. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 891-5. PMID 23232601 DOI: 10.1177/1352458512469693  0.413
2013 Smith K, Muther JJ, Duke AL, McKee E, Zheng NY, Wilson PC, James JA. Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis. Immunobiology. 218: 745-54. PMID 23084371 DOI: 10.1016/J.Imbio.2012.08.278  0.361
2013 Kaufman KM, Zhao J, Kelly JA, Hughes T, Adler A, Sanchez E, Ojwang JO, Langefeld CD, Ziegler JT, Williams AH, Comeau ME, Marion MC, Glenn SB, Cantor RM, Grossman JM, ... ... James JA, et al. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Annals of the Rheumatic Diseases. 72: 437-44. PMID 22904263 DOI: 10.1136/Annrheumdis-2012-201851  0.367
2013 Lessard CJ, Li H, Ice JA, Adrianto I, Jonsson R, Illei GG, Rischmueller M, Nordmark G, Mariette X, Miceli-Richard C, Wahren Herlenius M, Witte T, Brennan M, Omdal R, Gaffney PM, ... ... James JA, et al. OP0020 Identification of Multiple Sjögren’s Syndrome Susceptibility Loci Annals of the Rheumatic Diseases. 72: A54.3-A55. DOI: 10.1136/Annrheumdis-2013-Eular.225  0.325
2013 Sridharan S, Zhou T, Immermann F, Thanou A, James JA, Merrill JT. FRI0318 Comparison of lupus trial endpoints to a physician-weighted definition of improvement in the biomarkers of lupus disease (BOLD) study suggests improved discrimination using bicla (bilag based composite lupus assessment) vs sri (sle responder index) Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1445  0.314
2013 Hill AA, Immermann FW, Zhang Y, Reddy PS, Zhou T, O’Toole M, Whitley MZ, Masferrer J, Wu PW, Paradis T, Sridharan S, Merrill JT, James JA. FRI0003 Determination of interferon (IFN) signatures for sle patients may be critical for optimal treatment selection but depends on the genes chosen: report from the bold (biomarkers of lupus disease) study Annals of the Rheumatic Diseases. 72: A369.3-A370. DOI: 10.1136/Annrheumdis-2013-Eular.1131  0.337
2013 Seyhan A, O'Toole M, Zhang Y, Immermann F, Hill A, Reddy P, Masferrer J, Zhou T, Mounts W, Whitley M, Walker T, Kamp S, James J, Sridharan S, Merrill J, et al. OP0063 Impact of baseline interferon pathway activation on widespread gene expression changes with disease flare in lupus patients: Interim report from the bold (biomarkers of lupus disease) study: Annals of the Rheumatic Diseases. 71: 74.2-74. DOI: 10.1136/Annrheumdis-2012-Eular.1746  0.341
2012 Bruner BF, Guthridge JM, Lu R, Vidal G, Kelly JA, Robertson JM, Kamen DL, Gilkeson GS, Neas BR, Reichlin M, Scofield RH, Harley JB, James JA. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis and Rheumatism. 64: 3677-86. PMID 23112091 DOI: 10.1002/Art.34651  0.809
2012 Lu R, Robertson JM, Bruner BF, Guthridge JM, Neas BR, Nath SK, Kelly JA, Moser Sivils KL, Chakravarty EF, Kamen DL, Gilkeson GS, Wallace DJ, Weisman MH, Scofield RH, Harley JB, ... James JA, et al. Multiple Autoantibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a Large, Ethnically Diverse SLE Patient Cohort. Autoimmune Diseases. 2012: 819634. PMID 22988489 DOI: 10.1155/2012/819634  0.827
2012 Gaddy JR, Vista ES, Robertson JM, Dedeke AB, Roberts VC, Klein WS, Levin JH, Mota FH, Cooper TM, Grim GA, Khan S, James JA. Rheumatic disease among Oklahoma tribal populations: a cross-sectional study. The Journal of Rheumatology. 39: 1934-41. PMID 22896022 DOI: 10.3899/Jrheum.110984  0.309
2012 Sánchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA, Langefeld CD, Williams AH, Ziegler JT, Comeau ME, Marion MC, García-De La Torre I, Maradiaga-Ceceña MA, Cardiel MH, Esquivel-Valerio JA, Rodriguez-Amado J, ... ... James JA, et al. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis and Rheumatism. 64: 3687-94. PMID 22886787 DOI: 10.1002/Art.34650  0.363
2012 Popova L, Smith K, West AH, Wilson PC, James JA, Thompson LF, Air GM. Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses. Plos One. 7: e41895. PMID 22848649 DOI: 10.1371/Journal.Pone.0041895  0.313
2012 Adrianto I, Wang S, Wiley GB, Lessard CJ, Kelly JA, Adler AJ, Glenn SB, Williams AH, Ziegler JT, Comeau ME, Marion MC, Wakeland BE, Liang C, Kaufman KM, Guthridge JM, ... ... James JA, et al. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis and Rheumatism. 64: 3695-705. PMID 22833143 DOI: 10.1002/Art.34642  0.391
2012 Sun D, Raisley B, Langer M, Iyer JK, Vedham V, Ballard JL, James JA, Metcalf J, Coggeshall KM. Anti-peptidoglycan antibodies and Fcγ receptors are the key mediators of inflammation in Gram-positive sepsis. Journal of Immunology (Baltimore, Md. : 1950). 189: 2423-31. PMID 22815288 DOI: 10.4049/Jimmunol.1201302  0.338
2012 Kim K, Brown EE, Choi CB, Alarcón-Riquelme ME, Kelly JA, Glenn SB, Ojwang JO, Adler A, Lee HS, Boackle SA, Criswell LA, Alarcón GS, Edberg JC, Stevens AM, ... ... James JA, et al. Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Annals of the Rheumatic Diseases. 71: 1809-14. PMID 22523428 DOI: 10.1136/Annrheumdis-2011-201110  0.321
2012 James JA, Robertson JM. Lupus and Epstein-Barr. Current Opinion in Rheumatology. 24: 383-8. PMID 22504579 DOI: 10.1097/Bor.0B013E3283535801  0.399
2012 Guthridge JM, Clark DN, Templeton A, Dominguez N, Lu R, Vidal GS, Kelly JA, Kauffman KM, Harley JB, Gaffney PM, James JA, Poole BD. Effects of IRF5 lupus risk haplotype on pathways predicted to influence B cell functions. Journal of Biomedicine & Biotechnology. 2012: 594056. PMID 22500098 DOI: 10.1155/2012/594056  0.339
2012 Weckerle CE, Mangale D, Franek BS, Kelly JA, Kumabe M, James JA, Moser KL, Harley JB, Niewold TB. Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus. Arthritis and Rheumatism. 64: 2947-52. PMID 22488302 DOI: 10.1002/Art.34483  0.399
2012 Wang S, Adrianto I, Wiley GB, Lessard CJ, Kelly JA, Adler AJ, Glenn SB, Williams AH, Ziegler JT, Comeau ME, Marion MC, Wakeland BE, Liang C, Kaufman KM, Guthridge JM, ... ... James JA, et al. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes and Immunity. 13: 380-7. PMID 22476155 DOI: 10.1038/Gene.2012.6  0.406
2012 Lessard CJ, Adrianto I, Ice JA, Wiley GB, Kelly JA, Glenn SB, Adler AJ, Li H, Rasmussen A, Williams AH, Ziegler J, Comeau ME, Marion M, Wakeland BE, Liang C, ... ... James JA, et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. American Journal of Human Genetics. 90: 648-60. PMID 22464253 DOI: 10.1016/J.Ajhg.2012.02.023  0.38
2012 Smith K, Crowe SR, Garman L, Guthridge CJ, Muther JJ, McKee E, Zheng NY, Farris AD, Guthridge JM, Wilson PC, James JA. Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization. Vaccine. 30: 4276-83. PMID 22425791 DOI: 10.1016/J.Vaccine.2012.03.002  0.344
2012 Vista ES, Crowe SR, Thompson LF, Air GM, Robertson JM, Guthridge JM, James JA. Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus. Lupus. 21: 168-74. PMID 22235049 DOI: 10.1177/0961203311429554  0.417
2012 Namjou B, Choi CB, Harley IT, Alarcón-Riquelme ME, Kelly JA, Glenn SB, Ojwang JO, Adler A, Kim K, Gallant CJ, Boackle SA, Criswell LA, Kimberly RP, Brown EE, ... ... James JA, et al. Evaluation of TRAF6 in a large multiancestral lupus cohort. Arthritis and Rheumatism. 64: 1960-9. PMID 22231568 DOI: 10.1002/Art.34361  0.402
2012 Lin CP, Adrianto I, Lessard CJ, Kelly JA, Kaufman KM, Guthridge JM, Freedman BI, Anaya JM, Alarcón-Riquelme ME, Pons-Estel BA, Martin J, Glenn S, Adler A, Bae SC, ... ... James JA, et al. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes and Immunity. 13: 232-8. PMID 22189356 DOI: 10.1038/Gene.2011.82  0.377
2012 Hughes T, Adler A, Merrill JT, Kelly JA, Kaufman KM, Williams A, Langefeld CD, Gilkeson GS, Sanchez E, Martin J, Boackle SA, Stevens AM, Alarcón GS, Niewold TB, Brown EE, ... ... James JA, et al. Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 71: 694-9. PMID 22110124 DOI: 10.1136/Annrheumdis-2011-200385  0.331
2012 Niewold TB, Kelly JA, Kariuki SN, Franek BS, Kumar AA, Kaufman KM, Thomas K, Walker D, Kamp S, Frost JM, Wong AK, Merrill JT, Alarcón-Riquelme ME, Tikly M, Ramsey-Goldman R, ... ... James JA, et al. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 71: 463-8. PMID 22088620 DOI: 10.1136/Annrheumdis-2011-200463  0.513
2012 Castillejo-López C, Delgado-Vega AM, Wojcik J, Kozyrev SV, Thavathiru E, Wu YY, Sánchez E, Pöllmann D, López-Egido JR, Fineschi S, Domínguez N, Lu R, James JA, Merrill JT, Kelly JA, et al. Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Annals of the Rheumatic Diseases. 71: 136-42. PMID 21978998 DOI: 10.1136/Annrheumdis-2011-200085  0.341
2012 Hughes T, Adler A, Kelly JA, Kaufman KM, Williams AH, Langefeld CD, Brown EE, Alarcón GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Boackle SA, Stevens AM, Reveille JD, ... ... James JA, et al. Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. Arthritis and Rheumatism. 64: 485-92. PMID 21952918 DOI: 10.1002/Art.33354  0.356
2012 Anaya JM, Kim-Howard X, Prahalad S, Cherñavsky A, Cañas C, Rojas-Villarraga A, Bohnsack J, Jonsson R, Bolstad AI, Brun JG, Cobb B, Moser KL, James JA, Harley JB, Nath SK. Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. Autoimmunity Reviews. 11: 276-80. PMID 21840425 DOI: 10.1016/J.Autrev.2011.07.007  0.387
2012 Ritterhouse L, Maecker H, Fathman C, Merrill J, Guthridge J, James J. SLE patients and autoantibody-positive healthy individuals display unique cytokine profiles: shared features of inflammation as well as select features of immunosuppression in autoantibody-positive healthy individuals Arthritis Research & Therapy. 14: 1-28. DOI: 10.1186/Ar3960  0.694
2011 Ritterhouse LL, Crowe SR, Niewold TB, Merrill JT, Roberts VC, Dedeke AB, Neas BR, Thompson LF, Guthridge JM, James JA. B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels. Arthritis and Rheumatism. 63: 3931-41. PMID 22127709 DOI: 10.1002/Art.30598  0.652
2011 Gilkeson GS, James JA, Kamen DL, Knackstedt TJ, Maggi DR, Meyer AK, Ruth NM. The United States to Africa lupus prevalence gradient revisited Lupus. 20: 1095-1103. PMID 21917913 DOI: 10.1177/0961203311404915  0.402
2011 Sánchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD, Brown EE, Alarcón GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Vilá LM, Merrill JT, ... ... James JA, et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis and Rheumatism. 63: 3493-501. PMID 21792837 DOI: 10.1002/Art.30563  0.37
2011 Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng NY, Nishtala M, Wrammert J, Smith K, James JA, Dekker CL, Davis MM, Wilson PC, Greenberg HB, He XS. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. The Journal of Clinical Investigation. 121: 3109-19. PMID 21785218 DOI: 10.1172/Jci57834  0.309
2011 Mechelli R, Anderson J, Vittori D, Coarelli G, Annibali V, Cannoni S, Aloisi F, Salvetti M, James JA, Ristori G. Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins Multiple Sclerosis Journal. 17: 1290-1294. PMID 21757535 DOI: 10.1177/1352458511410515  0.421
2011 Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, Niewold TB, Kamen DL, Gilkeson GS, Ziegler JT, Langefeld CD, Alarcón GS, Edberg JC, Ramsey-Goldman R, Petri M, ... ... James JA, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 70: 1752-7. PMID 21719445 DOI: 10.1136/Ard.2011.154104  0.39
2011 Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, ... ... James JA, et al. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 76: 1989-95. PMID 21646624 DOI: 10.1212/Wnl.0B013E31821E552A  0.302
2011 Zhao J, Wu H, Khosravi M, Cui H, Qian X, Kelly JA, Kaufman KM, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Adler A, Glenn SB, Alarcón-Riquelme ME, ... ... James JA, et al. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. Plos Genetics. 7: e1002079. PMID 21637784 DOI: 10.1371/Journal.Pgen.1002079  0.351
2011 Crowe SR, Merrill JT, Vista ES, Dedeke AB, Thompson DM, Stewart S, Guthridge JM, Niewold TB, Franek BS, Air GM, Thompson LF, James JA. Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis and Rheumatism. 63: 2396-406. PMID 21598235 DOI: 10.1002/Art.30388  0.348
2011 Tan W, Sunahori K, Zhao J, Deng Y, Kaufman KM, Kelly JA, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Bae SC, Lee JH, Lee JS, Chang DM, ... ... James JA, et al. Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis and Rheumatism. 63: 2755-63. PMID 21590681 DOI: 10.1002/Art.30452  0.388
2011 Ritterhouse LL, Crowe SR, Niewold TB, Kamen DL, Macwana SR, Roberts VC, Dedeke AB, Harley JB, Scofield RH, Guthridge JM, James JA. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 70: 1569-74. PMID 21586442 DOI: 10.1136/Ard.2010.148494  0.665
2011 Crowe SR, Garman L, Engler RJ, Farris AD, Ballard JD, Harley JB, James JA. Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity. Vaccine. 29: 3670-8. PMID 21420416 DOI: 10.1016/J.Vaccine.2011.03.011  0.376
2011 Bruner BF, Vista ES, Wynn DM, James JA. Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes. Clinical and Experimental Immunology. 164: 330-6. PMID 21401576 DOI: 10.1111/J.1365-2249.2011.04372.X  0.82
2011 Adrianto I, Wen F, Templeton A, Wiley G, King JB, Lessard CJ, Bates JS, Hu Y, Kelly JA, Kaufman KM, Guthridge JM, Alarcón-Riquelme ME, Anaya JM, Bae SC, ... ... James JA, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nature Genetics. 43: 253-8. PMID 21336280 DOI: 10.1038/Ng.766  0.416
2011 Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, Alarcón-Riquelme ME, Gallant CJ, Boackle SA, Criswell LA, Kimberly RP, Brown E, Edberg J, Stevens AM, Jacob CO, ... ... James JA, et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes and Immunity. 12: 270-9. PMID 21270825 DOI: 10.1038/Gene.2010.73  0.346
2011 Mowry EM, James JA, Krupp LB, Waubant E. Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 666-71. PMID 21212086 DOI: 10.1177/1352458510394398  0.317
2011 Lessard CJ, Adrianto I, Kelly JA, Kaufman KM, Grundahl KM, Adler A, Williams AH, Gallant CJ, Anaya JM, Bae SC, Boackle SA, Brown EE, Chang DM, Criswell LA, ... ... James JA, et al. Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. American Journal of Human Genetics. 88: 83-91. PMID 21194677 DOI: 10.1016/J.Ajhg.2010.11.014  0.337
2011 Navarra SV, Ishimori MI, Uy EA, Hamijoyo L, Sama J, James JA, Holers VM, Weisman MH. Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives. Lupus. 20: 537-43. PMID 21183559 DOI: 10.1177/0961203310385164  0.485
2011 Weckerle CE, Franek BS, Kelly JA, Kumabe M, Mikolaitis RA, Green SL, Utset TO, Jolly M, James JA, Harley JB, Niewold TB. Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis and Rheumatism. 63: 1044-53. PMID 21162028 DOI: 10.1002/Art.30187  0.405
2011 Rasmussen A, Sevier S, Kelly JA, Glenn SB, Aberle T, Cooney CM, Grether A, James E, Ning J, Tesiram J, Morrisey J, Powe T, Drexel M, Daniel W, Namjou B, ... ... James JA, et al. The lupus family registry and repository. Rheumatology (Oxford, England). 50: 47-59. PMID 20864496 DOI: 10.1093/Rheumatology/Keq302  0.328
2011 Mowry EM, James JA, Krupp LB, Waubant E. Erratum: Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis (Multiple Sclerosis Journal (2011) 17: 6 (666-671) DOI: 10.1177/1352458511394398) Multiple Sclerosis Journal. 17. DOI: 10.1177/1352458511429240  0.339
2010 Bruner BF, Vista ES, Wynn DM, Harley JB, James JA. Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener’s granulomatosis. Clinical and Experimental Immunology. 162: 262-70. PMID 21077276 DOI: 10.1111/J.1365-2249.2010.04251.X  0.814
2010 Ristori G, Mechelli R, Anderson J, Mengoni F, Sauzullo I, Annibali V, Cannoni S, Aloisi F, James JA, Salvetti M. Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 1527-8. PMID 20798134 DOI: 10.1177/1352458510380090  0.351
2010 Harley IT, Niewold TB, Stormont RM, Kaufman KM, Glenn SB, Franek BS, Kelly JA, Kilpatrick JR, Hutchings D, Divers J, Bruner GR, Edberg JC, McGwin G, Petri MA, Ramsey-Goldman R, ... ... James JA, et al. The role of genetic variation near interferon-kappa in systemic lupus erythematosus. Journal of Biomedicine & Biotechnology. 2010. PMID 20706608 DOI: 10.1155/2010/706825  0.384
2010 Crowe SR, Ash LL, Engler RJ, Ballard JD, Harley JB, Farris AD, James JA. Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge. The Journal of Infectious Diseases. 202: 251-60. PMID 20533877 DOI: 10.1086/653495  0.381
2010 Fürnrohr BG, Wach S, Kelly JA, Haslbeck M, Weber CK, Stach CM, Hueber AJ, Graef D, Spriewald BM, Manger K, Herrmann M, Kaufman KM, Frank SG, Goodmon E, James JA, et al. Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 69: 1983-9. PMID 20498198 DOI: 10.1136/Ard.2009.122630  0.358
2010 Aggarwal R, Namjou B, Li S, D'Souza A, Tsao BP, Bruner BF, James JA, Scofield RH. Male-only systemic lupus. The Journal of Rheumatology. 37: 1480-7. PMID 20472921 DOI: 10.3899/Jrheum.090726  0.788
2010 Heinlen LD, Ritterhouse LL, McClain MT, Keith MP, Neas BR, Harley JB, James JA. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. Journal of Molecular Medicine (Berlin, Germany). 88: 719-27. PMID 20396862 DOI: 10.1007/S00109-010-0618-1  0.808
2010 Heinlen LD, McClain MT, Ritterhouse LL, Bruner BF, Edgerton CC, Keith MP, James JA, Harley JB. 60 kD Ro and nRNP A frequently initiate human lupus autoimmunity. Plos One. 5: e9599. PMID 20224770 DOI: 10.1371/Journal.Pone.0009599  0.8
2010 Harley JB, James JA. Everyone comes from somewhere: systemic lupus erythematosus and Epstein-Barr virus induction of host interferon and humoral anti-Epstein-Barr nuclear antigen 1 immunity. Arthritis and Rheumatism. 62: 1571-5. PMID 20178135 DOI: 10.1002/Art.27421  0.416
2010 Kim-Howard X, Maiti AK, Anaya JM, Bruner GR, Brown E, Merrill JT, Edberg JC, Petri MA, Reveille JD, Ramsey-Goldman R, Alarcon GS, Vyse TJ, Gilkeson G, Kimberly RP, James JA, et al. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Annals of the Rheumatic Diseases. 69: 1329-32. PMID 19939855 DOI: 10.1136/Ard.2009.120543  0.393
2010 Edgar CE, Terrell D, Vesely SK, Turner S, Dozmorov I, Niewold TB, Frank MB, Bebak M, Klein W, Merrill JT, Moser KL, James JA, George JN, Farris AD. Elevated Serum Type I Interferon Activity and Type I Interferon Peripheral Blood Gene Signature In a Subset of Patients with Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura. Blood. 116: 3694-3694. DOI: 10.1182/Blood.V116.21.3694.3694  0.406
2010 Terrell DR, Al-Nouri Z, James JA, Strebel JAKH, Lämmle B, Vesely SK, George JN. Are Patients Who Have Recovered From ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP) at Risk for Developing Systemic Lupus Erythematosus (SLE)? Blood. 116: 2519-2519. DOI: 10.1182/Blood.V116.21.2519.2519  0.46
2010 Lu R, Vidal GS, Kelly JA, Delgado-Vega AM, Howard XK, MacWana SR, Dominguez N, Klein W, Burrell C, Harley IT, Kaufman KM, Bruner GR, Moser KL, Gaffney PM, Gilkeson GS, ... ... James JA, et al. Erratum: Genetic associations of LYN with systemic lupus erythematosus (Genes and Immunity (2009) 10 (397-403) DOI: 10.1038/gene.2009.19) Genes and Immunity. 11: 98-98. DOI: 10.1038/Gene.2009.102  0.308
2010 Weckerle C, Franek B, Kelly J, Mikolaitis R, Jolly M, Utset T, Bruner G, James J, Harley J, Niewold T. Ancestral Differences in Associations Between Disease Manifestations and Serum IFN-α in SLE Patients Clinical Immunology. 135. DOI: 10.1016/J.Clim.2010.03.346  0.367
2009 Cooper G, Gilbert K, Greidinger E, James J, Pfau J, Reinlib L, Richardson B, Rose N. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. CiêNcia & SaúDe Coletiva. 14: 1865-76. PMID 19851599 DOI: 10.1590/S1413-81232009000500028  0.311
2009 Feng J, Gulati U, Zhang X, Keitel WA, Thompson DM, James JA, Thompson LF, Air GM. Antibody quantity versus quality after influenza vaccination. Vaccine. 27: 6358-62. PMID 19840673 DOI: 10.1016/J.Vaccine.2009.06.090  0.366
2009 Nguyen ML, Terzyan S, Ballard JD, James JA, Farris AD. The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes. Infection and Immunity. 77: 4714-23. PMID 19720758 DOI: 10.1128/Iai.00749-09  0.397
2009 Webb R, Merrill JT, Kelly JA, Sestak A, Kaufman KM, Langefeld CD, Ziegler J, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Alarcón GS, Vilá LM, Alarcón-Riquelme ME, ... James JA, et al. A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis and Rheumatism. 60: 2402-7. PMID 19644854 DOI: 10.1002/Art.24658  0.365
2009 Namjou B, Gray-McGuire C, Sestak AL, Gilkeson GS, Jacob CO, Merrill JT, James JA, Wakeland EK, Li QZ, Langefeld CD, Divers J, Ziegler J, Moser KL, Kelly JA, Kaufman KM, et al. Evaluation of C1q genomic region in minority racial groups of lupus. Genes and Immunity. 10: 517-24. PMID 19440201 DOI: 10.1038/Gene.2009.33  0.355
2009 Douglas KB, Windels DC, Zhao J, Gadeliya AV, Wu H, Kaufman KM, Harley JB, Merrill J, Kimberly RP, Alarcón GS, Brown EE, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, ... ... James JA, et al. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes and Immunity. 10: 457-69. PMID 19387458 DOI: 10.1038/Gene.2009.27  0.323
2009 Bates JS, Lessard CJ, Leon JM, Nguyen T, Battiest LJ, Rodgers J, Kaufman KM, James JA, Gilkeson GS, Kelly JA, Humphrey MB, Harley JB, Gray-McGuire C, Moser KL, Gaffney PM. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes and Immunity. 10: 470-7. PMID 19387456 DOI: 10.1038/Gene.2009.31  0.329
2009 Lu R, Vidal GS, Kelly JA, Delgado-Vega AM, Howard XK, Macwana SR, Dominguez N, Klein W, Burrell C, Harley IT, Kaufman KM, Bruner GR, Moser KL, Gaffney PM, Gilkeson GS, ... ... James JA, et al. Genetic associations of LYN with systemic lupus erythematosus. Genes and Immunity. 10: 397-403. PMID 19369946 DOI: 10.1038/Gene.2009.19  0.37
2009 Guo L, Deshmukh H, Lu R, Vidal GS, Kelly JA, Kaufman KM, Dominguez N, Klein W, Kim-Howard X, Bruner GR, Scofield RH, Moser KL, Gaffney PM, Dozmorov IM, Gilkeson GS, ... ... James JA, et al. Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population. Genes and Immunity. 10: 531-8. PMID 19339986 DOI: 10.1038/Gene.2009.18  0.423
2009 Namjou B, Sestak AL, Armstrong DL, Zidovetzki R, Kelly JA, Jacob N, Ciobanu V, Kaufman KM, Ojwang JO, Ziegler J, Quismorio FP, Reiff A, Myones BL, Guthridge JM, Nath SK, ... ... James JA, et al. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis and Rheumatism. 60: 1085-95. PMID 19333953 DOI: 10.1002/Art.24387  0.391
2009 Webb R, Wren JD, Jeffries M, Kelly JA, Kaufman KM, Tang Y, Frank MB, Merrill J, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Alarcón GS, Vilá LM, ... ... James JA, et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 60: 1076-84. PMID 19333917 DOI: 10.1002/Art.24360  0.364
2009 Poole BD, Schneider RI, Guthridge JM, Velte CA, Reichlin M, Harley JB, James JA. Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus. Arthritis and Rheumatism. 60: 848-59. PMID 19248110 DOI: 10.1002/Art.24306  0.506
2009 Poole BD, Templeton AK, Guthridge JM, Brown EJ, Harley JB, James JA. Aberrant Epstein-Barr viral infection in systemic lupus erythematosus Autoimmunity Reviews. 8: 337-342. PMID 19167523 DOI: 10.1016/J.Autrev.2008.12.008  0.429
2009 Han S, Kim-Howard X, Deshmukh H, Kamatani Y, Viswanathan P, Guthridge JM, Thomas K, Kaufman KM, Ojwang J, Rojas-Villarraga A, Baca V, Orozco L, Rhodes B, Choi CB, Gregersen PK, ... ... James JA, et al. Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). Human Molecular Genetics. 18: 1171-80. PMID 19129174 DOI: 10.1093/Hmg/Ddp007  0.356
2009 Nguyen ML, Crowe SR, Kurella S, Teryzan S, Cao B, Ballard JD, James JA, Farris AD. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies. Infection and Immunity. 77: 162-9. PMID 18981257 DOI: 10.1128/Iai.00788-08  0.406
2009 Douglas KB, Windels DC, Zhao J, Gadeliya AV, Wu H, Kaufman KM, Harley JB, Merrill J, Kimberly RP, Alarcón GS, Brown EE, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, ... ... James JA, et al. Erratum: Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing Genes & Immunity. 10: 606-606. DOI: 10.1038/Gene.2009.42  0.345
2009 Cole L, Heinlen L, Harley J, James J. S.18. Ribosomal P Autoantibodies are Commonly Present Before SLE Onset and are Directed Against Non-C Terminal Portions of the Protein Clinical Immunology. 131: S138. DOI: 10.1016/J.Clim.2009.03.405  0.758
2009 Cole L, Roberts V, Dedeke A, Klein W, Crowe S, James J. F.84. Influence of Vitamin D Deficiency on Humoral Autoimmunity and Antigen Specific Immunity in Systemic Lupus Erythematosus Clinical Immunology. 131. DOI: 10.1016/J.Clim.2009.03.342  0.38
2008 Sestak A, Nath S, Kelly J, Bruner G, James J, Harley J. Patients with familial and sporadic onset SLE have similar clinical profiles but vary profoundly by race. Lupus. 17: 1004-1009. PMID 18852224 DOI: 10.1177/0961203308091969  0.361
2008 Poole BD, Gross T, Maier S, Harley JB, James JA. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments Journal of Autoimmunity. 31: 362-371. PMID 18849143 DOI: 10.1016/J.Jaut.2008.08.007  0.434
2008 Jackson SM, Wilson PC, James JA, Capra JD. Human B cell subsets. Advances in Immunology. 98: 151-224. PMID 18772006 DOI: 10.1016/S0065-2776(08)00405-7  0.312
2008 Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, James J, Air GM, Capra JD, Ahmed R, Wilson PC. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature. 453: 667-71. PMID 18449194 DOI: 10.1038/Nature06890  0.314
2008 Han S, Guthridge JM, Harley IT, Sestak AL, Kim-Howard X, Kaufman KM, Namjou B, Deshmukh H, Bruner G, Espinoza LR, Gilkeson GS, Harley JB, James JA, Nath SK. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction. Plos One. 3: e0001757. PMID 18335026 DOI: 10.1371/Journal.Pone.0001757  0.364
2008 Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP, Alarcón-Riquelme ME, James JA, Vyse TJ, Gilkeson GS, Choi CB, Scofield RH, Bae SC, Nath SK, Harley JB. Common variants within MECP2 confer risk of systemic lupus erythematosus. Plos One. 3: e1727. PMID 18320046 DOI: 10.1371/Journal.Pone.0001727  0.39
2008 Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, Merrill JT, James JA, Frank SG, Reams E, Brown EE, Gibson AW, Marion MC, Langefeld CD, Li QZ, Karp DR, et al. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes and Immunity. 9: 187-94. PMID 18288123 DOI: 10.1038/Gene.2008.4  0.362
2008 Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, Gilkeson GS, Chen W, Zhu C, McEver RP, Kimberly RP, Alarcón-Riquelme ME, Vyse TJ, Li QZ, Wakeland EK, Merrill JT, ... James JA, et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nature Genetics. 40: 152-4. PMID 18204448 DOI: 10.1038/Ng.71  0.355
2008 Harley JB, Alarcón-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD, Nath SK, Guthridge JM, Cobb BL, Mirel DB, Marion MC, ... ... James JA, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genetics. 40: 204-10. PMID 18204446 DOI: 10.1038/Ng.81  0.378
2008 Sawalha AH, Kaufman KM, Kelly JA, Adler AJ, Aberle T, Kilpatrick J, Wakeland EK, Li QZ, Wandstrat AE, Karp DR, James JA, Merrill JT, Lipsky P, Harley JB. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 67: 458-61. PMID 17720724 DOI: 10.1136/Ard.2007.075424  0.332
2008 Thanou-Stavraki A, James JA. Primary Sjogren's Syndrome: Current and Prospective Therapies Seminars in Arthritis and Rheumatism. 37: 273-292. PMID 17714766 DOI: 10.1016/J.Semarthrit.2007.06.002  0.352
2008 Nath S, Han S, Kim-Howard X, Deshmukh H, Viswanathan P, Bruner G, Kelly J, Gilkeson G, McEver R, Kimberly R, Vyse T, Chen W, Zhu C, Alarcón-Riquelme M, Wakeland E, ... ... James J, et al. Sa.54. Positional Identification of Integrin- αMβ2 (ITGAM) as a Susceptibility Gene for Systematic Lupus Erythematosus (SLE) Clinical Immunology. 127: S98. DOI: 10.1016/J.Clim.2008.03.275  0.354
2008 Sawalha A, Webb R, Han S, Kelly J, Kaufman K, Kimberly R, Alarcón-Riquelme M, James J, Vyse T, Gilkeson G, Choi C, Scofield H, Bae S, Nath S, Harley J. Sa.9. Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus Clinical Immunology. 127: S83. DOI: 10.1016/J.Clim.2008.03.230  0.367
2008 Cobb B, Kaufman K, Wang Y, Kelly J, Jonsson R, Bolstad AI, Brun J, Rischmueller M, Lester S, Witte T, Mariette X, Kimberly R, Edberg J, Bae S, Jacob C, ... ... James J, et al. OR.104. Association of Sjögren's Syndrome (SS) and Systemic Lupus Erythematosus (SLE) with BLK Clinical Immunology. 127: S41. DOI: 10.1016/J.Clim.2008.03.111  0.386
2007 James JA, Kim-Howard XR, Bruner BF, Jonsson MK, McClain MT, Arbuckle MR, Walker C, Dennis GJ, Merrill JT, Harley JB. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus. 16: 401-9. PMID 17664230 DOI: 10.1177/0961203307078579  0.805
2007 Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, James JA. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis and Rheumatism. 56: 2344-51. PMID 17599763 DOI: 10.1002/Art.22665  0.806
2007 George JN, Vesely SK, James JA. Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus Southern Medical Journal. 100: 512-514. PMID 17534089 DOI: 10.1097/Smj.0B013E318046583F  0.373
2007 Swisher KK, Lewis QF, James JA, Hovinga JAK, Lämmle B, Terrell DR, Vesely SK, George JN. The Frequency of Rheumatic Disease Autoantibodies in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP). Blood. 110: 2090-2090. DOI: 10.1182/Blood.V110.11.2090.2090  0.438
2007 Heinlen L, McClain M, Prestigiacomo T, Bruner B, Binder S, Edgerton C, Rubertone M, James J, Harley J. Autoantibody Onset Prior to SLE Diagnosis Follows Predictable Patterns of Development Clinical Immunology. 123: S101. DOI: 10.1016/J.Clim.2007.03.467  0.773
2007 Sawalha AH, Kaufman K, Kelly J, Aberle T, Adler A, Kilpatrick J, Wakeland E, Li Q, Wandstrat A, James J, Merrill J, Lipsky P, Harley JB. OR.81Genetic Association of IL-21 Polymorphisms with Systemic Lupus Erythematosus Clinical Immunology. 123. DOI: 10.1016/J.Clim.2007.03.021  0.32
2006 Akbarali Y, Matousek-Ronck J, Hunt L, Staudt L, Reichlin M, Guthridge JM, James JA. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. Journal of Autoimmunity. 27: 272-80. PMID 17210244 DOI: 10.1016/J.Jaut.2006.10.001  0.466
2006 Harley JB, Harley ITW, Guthridge JM, James JA. The curiously suspicious: a role for Epstein-Barr virus in lupus Lupus. 15: 768-777. PMID 17153849 DOI: 10.1177/0961203306070009  0.461
2006 Harley JB, James JA. Epstein-Barr virus infection induces lupus autoimmunity Bulletin of the Nyu Hospital For Joint Diseases. 64: 45-50. PMID 17121489  0.406
2006 James JA, Harley JB, Scofield RH. Epstein-Barr virus and systemic lupus erythematosus Current Opinion in Rheumatology. 18: 462-467. PMID 16896283 DOI: 10.1097/01.Bor.0000240355.37927.94  0.414
2006 Kaufman KM, Kelly JA, Herring BJ, Adler AJ, Glenn SB, Namjou B, Frank SG, Dawson SL, Bruner GR, James JA, Harley JB. Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis and Rheumatism. 54: 2533-40. PMID 16868974 DOI: 10.1002/Art.21963  0.373
2006 Ramos PS, Kelly JA, Gray-McGuire C, Bruner GR, Leiran AN, Meyer CM, Namjou B, Espe KJ, Ortmann WA, Reichlin M, Langefeld CD, James JA, Gaffney PM, Behrens TW, Harley JB, et al. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes and Immunity. 7: 417-32. PMID 16775618 DOI: 10.1038/Sj.Gene.6364316  0.4
2006 Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus Autoimmunity. 39: 63-70. PMID 16455583 DOI: 10.1080/08916930500484849  0.477
2006 McClain MT, Poole BD, Bruner BF, Kaufman KM, Harley JB, James JA. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis and Rheumatism. 54: 360-8. PMID 16385527 DOI: 10.1002/Art.21682  0.807
2006 Heinlen L, McClain M, Pachner A, Harley J, James J. Sa.16. Multiple Sclerosis Patients Exhibit a Unique Humoral Response to the Epstein-Barr Virus Nuclear Antigen-1 Clinical Immunology. 119: S110. DOI: 10.1016/J.Clim.2006.04.248  0.792
2006 Heinlen L, McClain M, Miner J, Scofield H, Harley J, James J. F.66. SLE Patient Anti-Ro 169 Antibodies Are Associated with Leucopenia and Bind the Surface of Neutrophils Clinical Immunology. 119: S74. DOI: 10.1016/J.Clim.2006.04.106  0.796
2005 Bruner BF, Wynn DM, Reichlin M, Harley JB, James JA. Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region. Annals of the New York Academy of Sciences. 1051: 390-403. PMID 16126981 DOI: 10.1196/Annals.1361.081  0.809
2005 Scofield RH, Kurien BT, Ganick S, McClain MT, Pye Q, James JA, Schneider RI, Broyles RH, Bachmann M, Hensley K. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radical Biology & Medicine. 38: 719-28. PMID 15721982 DOI: 10.1016/J.Freeradbiomed.2004.11.001  0.676
2005 McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nature Medicine. 11: 85-9. PMID 15619631 DOI: 10.1038/Nm1167  0.831
2005 Shu C, Guo L, Bruner G, Gilkeson G, Kamen D, Tang YH, Dozmorov I, Kelly J, Ning J, Williams D, Pongratz C, James J, Guthridge JM, Harley JB. 358 DIFFERENTIAL GENE EXPRESSION IN B CELLS FROM GULLAH LUPUS PATIENTS AND CONTROLS. Journal of Investigative Medicine. 53: S316.6-S317. DOI: 10.2310/6650.2005.00006.357  0.345
2005 Guo L, Dominguez N, Dozmorov I, Tang YH, Namjou B, Kelly J, Hutchings D, Bruner G, Klein W, James J, Kaufman K, Scofield H, Guthridge JM, Harley JB. 35 Gene Expression Analysis Of European-American Lupus Patients With Thyroid Disease Compared To Matched Controls Journal of Investigative Medicine. 53. DOI: 10.2310/6650.2005.00006.34  0.334
2004 McClain MT, Arbuckle MR, Heinlen LD, Dennis GJ, Roebuck J, Rubertone MV, Harley JB, James JA. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis and Rheumatism. 50: 1226-32. PMID 15077305 DOI: 10.1002/Art.20120  0.82
2004 McClain MT, Lutz CS, Kaufman KM, Faig OZ, Gross TF, James JA. Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response. Proceedings of the National Academy of Sciences of the United States of America. 101: 3551-6. PMID 14988508 DOI: 10.1073/Pnas.0306267101  0.643
2004 Hunt L, Li X, James J, Terrell DR, Lammle B, Kremer-Hovinga J, George JN, Vesely SK. Thrombotic Thrombocytopenic Purpura (TTP) and Systemic Lupus Erythematosus (SLE): Distinct but Potentially Overlapping Syndromes. Blood. 104: 858-858. DOI: 10.1182/Blood.V104.11.858.858  0.41
2004 Harley JB, Kelly JA, McClain MT, James JA. 9 THE GENES, ENVIRONMENT, AND HOST IMMUNE RESPONSES IN THE ETIOLOGY OF SYSTEMIC LUPUS ERYTHEMATOSUS. Journal of Investigative Medicine. 52: S258.4-S258. DOI: 10.1136/Jim-52-Suppl1-562  0.637
2003 Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England Journal of Medicine. 349: 1526-33. PMID 14561795 DOI: 10.1056/Nejmoa021933  0.682
2003 Heinlen LD, McClain MT, Kim X, Quintero DR, James JA, Harley JB, Scofield RH. Anti-Ro and anti-nRNP response in unaffected family members of SLE patients. Lupus. 12: 335-7. PMID 12729062 DOI: 10.1191/0961203303lu377xx  0.791
2003 Kaufman KM, Kirby MY, Harley JB, James JA. Peptide mimics of a major lupus epitope of SmB/B'. Annals of the New York Academy of Sciences. 987: 215-29. PMID 12727642 DOI: 10.1111/J.1749-6632.2003.Tb06051.X  0.408
2003 McClain MT, Rapp EC, Harley JB, James JA. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. Journal of Medical Virology. 70: 253-7. PMID 12696112 DOI: 10.1002/Jmv.10385  0.69
2003 Arbuckle MR, James JA, Dennis GJ, Rubertone MV, McClain MT, Kim XR, Harley JB. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus. 12: 99-106. PMID 12630753 DOI: 10.1191/0961203303Lu334Oa  0.652
2003 Harley J, Kelly J, James J. Origins of systemic lupus erythematosus: genes, environment, and host immune response Arthritis Research & Therapy. 5: 26-26. DOI: 10.1186/Ar827  0.404
2002 Namjou B, Nath SK, Kilpatrick J, Kelly JA, Reid J, James JA, Harley JB. Stratification of pedigrees multiplex for systemic lupus erythematosus and for self-reported rheumatoid arthritis detects a systemic lupus erythematosus susceptibility gene (SLER1) at 5p15.3. Arthritis and Rheumatism. 46: 2937-45. PMID 12428235 DOI: 10.1002/Art.10588  0.38
2002 Scofield RH, Pierce PG, James JA, Kaufman KM, Kurien BT. Immunization with peptides from 60 kDa Ro in diverse mouse strains. Scandinavian Journal of Immunology. 56: 477-83. PMID 12410797 DOI: 10.1046/J.1365-3083.2002.01159.X  0.367
2002 McClain MT, Scofield RH, Kurien BT, Gross TF, James JA. Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE. Scandinavian Journal of Immunology. 56: 399-407. PMID 12234261 DOI: 10.1046/J.1365-3083.2002.01141.X  0.683
2002 Quintero-Del-Rio AI, Kelly JA, Kilpatrick J, James JA, Harley JB. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3) Genes and Immunity. 3. PMID 12215904 DOI: 10.1038/Sj.Gene.6363901  0.323
2002 Sawalha AH, Namjou B, Nath SK, Kilpatrick J, Germundson A, Kelly JA, Hutchings D, James J, Harley J. Genetic linkage of systemic lupus erythematosus with chromosome 11q14 (SLEH1) in African-American families stratified by a nucleolar antinuclear antibody pattern Genes and Immunity. 3. PMID 12215899 DOI: 10.1038/Sj.Gene.6363904  0.359
2002 Olson JM, Song Y, Dudek DM, Moser KL, Kelly JA, Bruner GR, Downing KJ, Berry CK, James JA, Harley JB. A genome screen of systemic lupus erythematosus using affected-relative-pair linkage analysis with covariates demonstrates genetic heterogeneity. Genes and Immunity. 3: S5-S12. PMID 12215896 DOI: 10.1038/Sj.Gene.6363860  0.319
2002 Lutz CS, McClain MT, Harley JB, James JA. Anti-U1A monoclonal antibodies recognize unique epitope targets of U1A which are involved in the binding of U1 RNA. Journal of Molecular Recognition : Jmr. 15: 163-70. PMID 12203842 DOI: 10.1002/Jmr.569  0.637
2002 McClain MT, Ramsland PA, Kaufman KM, James JA. Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. Journal of Immunology (Baltimore, Md. : 1950). 168: 2054-62. PMID 11823543 DOI: 10.4049/Jimmunol.168.4.2054  0.625
2001 James JA, Harley JB, Scofield RH. Role of viruses in systemic lupus erythematosus and Sjögren syndrome Current Opinion in Rheumatology. 13: 370-376. PMID 11604590 DOI: 10.1097/00002281-200109000-00005  0.33
2001 McClain MT, Harley JB, James JA. The role of Epstein-Barr virus in systemic lupus erythematosus. Frontiers in Bioscience : a Journal and Virtual Library. 6: E137-47. PMID 11578968  0.649
2001 Kaufman KM, Kirby MY, McClain MT, Harley JB, James JA. Lupus autoantibodies recognize the product of an alternative open reading frame of SmB/B'. Biochemical and Biophysical Research Communications. 285: 1206-12. PMID 11478783 DOI: 10.1006/Bbrc.2001.5302  0.68
2001 Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scandinavian Journal of Immunology. 54: 211-9. PMID 11439169 DOI: 10.1046/J.1365-3083.2001.00959.X  0.459
2001 James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, Harley JB. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure Arthritis and Rheumatism. 44: 1122-1126. PMID 11352244 DOI: 10.1002/1529-0131(200105)44:5<1122::Aid-Anr193>3.0.Co;2-D  0.388
2001 del Rincon I, Zeidel M, Rey E, Harley JB, James JA, Fischbach M, Sanz I. Delineation of the human systemic lupus erythematosus anti-Smith antibody response using phage-display combinatorial libraries. Journal of Immunology (Baltimore, Md. : 1950). 165: 7011-6. PMID 11120828 DOI: 10.4049/Jimmunol.165.12.7011  0.435
1999 Hal Scofield R, James JA. Immunization as a model for systemic lupus erythematosus Seminars in Arthritis and Rheumatism. 29: 140-147. PMID 10622678 DOI: 10.1016/S0049-0172(99)80025-0  0.389
1999 Arbuckle MR, Reichlin M, Harley JB, James JA. Shared early autoantibody recognition events in the development of anti- Sm B/B' in human lupus Scandinavian Journal of Immunology. 50: 447-455. PMID 10564545 DOI: 10.1046/j.1365-3083.1999.00640.x  0.366
1999 Scofield RH, Kaufman KM, Baber U, James JA, Harley JB, Kurien BT. Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse Arthritis and Rheumatism. 42: 1017-1024. PMID 10323459 DOI: 10.1002/1529-0131(199905)42:5<1017::Aid-Anr22>3.0.Co;2-7  0.334
1999 James JA, McClain MT, Koelsch G, Williams DG, Harley JB. Side-chain specificities and molecular modelling of peptide determinants for two anti-Sm B/B' autoantibodies. Journal of Autoimmunity. 12: 43-9. PMID 10028021 DOI: 10.1006/Jaut.1998.0252  0.638
1999 Reichlin M, Broyles TF, Hubscher O, James J, Lehman TA, Palermo R, Stafford HA, Taylor-Albert E, Wolfson-Reichlin M. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis and Rheumatism. 42: 69-75. PMID 9920016 DOI: 10.1002/1529-0131(199901)42:1<69::Aid-Anr9>3.0.Co;2-J  0.464
1998 Arbuckle MR, Schilling AR, Harley JB, James JA. A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif. Journal of Autoimmunity. 11: 431-8. PMID 9802926 DOI: 10.1006/Jaut.1998.0227  0.498
1998 James JA, Harley JB. B-cell epitope spreading in autoimmunity Immunological Reviews. 164: 185-200. PMID 9795776 DOI: 10.1111/J.1600-065X.1998.Tb01220.X  0.39
1997 James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJA, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus Journal of Clinical Investigation. 100: 3019-3026. PMID 9399948 DOI: 10.1172/Jci119856  0.336
1997 James JA, Scofield RH, Harley JB. Lupus humoral autoimmunity after short peptide immunization Annals of the New York Academy of Sciences. 815: 124-127. PMID 9186649 DOI: 10.1111/J.1749-6632.1997.Tb52054.X  0.318
1996 Ge Q, Wu Y, James JA, Targoff IN. Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen Arthritis and Rheumatism. 39: 1588-1595. PMID 8814071 DOI: 10.1002/Art.1780390920  0.352
1996 Li F, Erickson HP, James JA, Moore KL, Cummings RD, McEver RP. Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies Journal of Biological Chemistry. 271: 6342-6348. PMID 8626430 DOI: 10.1074/Jbc.271.11.6342  0.316
1996 James JA, Gross T, Harley JB. Short peptide immunization induces lupus humoral autoimmuntty and systemic disease Journal of Investigative Medicine. 44.  0.344
1995 James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity Journal of Experimental Medicine. 181: 453-461. PMID 7530756 DOI: 10.1084/Jem.181.2.453  0.424
1995 Harley JB, James JA. Autoepitopes in lupus Journal of Laboratory and Clinical Medicine. 126: 509-516. PMID 7490509  0.316
1994 James JA, Mamula MJ, Harley JB. Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRL lpr/lpr antibodies Clinical and Experimental Immunology. 98: 419-426. PMID 7527740 DOI: 10.1111/J.1365-2249.1994.Tb05507.X  0.434
1994 James JA, Scofield RH, Harley JB. Basic amino acids predominate in the sequential autoantigenic determinants of the small nuclear 70K ribonucleoprotein Scandinavian Journal of Immunology. 39: 557-566. PMID 7516572 DOI: 10.1111/J.1365-3083.1994.Tb03413.X  0.374
1991 Scofield RH, Dickey WD, Jackson KW, James JA, Harley JB. A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: sequence similarity with a viral protein. Journal of Clinical Immunology. 11: 378-388. PMID 1722217 DOI: 10.1007/Bf00918804  0.395
1990 James JA, Dickey WD, Fujisaku A, O'Brien CA, Deutscher SL, Keene JD, Harley JB. Antigenicity of a recombinant Ro (SS-A) fusion protein. Arthritis and Rheumatism. 33: 102-6. PMID 1689160 DOI: 10.1002/Art.1780330114  0.342
Show low-probability matches.